Collins Cooper C. 4
4 · TherapeuticsMD, Inc. · Filed Jun 10, 2020
Insider Transaction Report
Form 4
Collins Cooper C.
Director
Transactions
- Purchase
Common Stock
2020-06-09$1.45/sh+47,500$68,875→ 140,000 total - Purchase
Common Stock
2020-06-08$1.45/sh+26,500$38,425→ 92,500 total